Etirinotecan Pegol Treatment for Patients with Metastatic Breast Cancer and Brain Metastases - Reply

Debu Tripathy; Sara M. Tolaney; Mary Tagliaferri

doi:10.1001/jamaoncol.2022.4346

Etirinotecan Pegol Treatment for Patients with Metastatic Breast Cancer and Brain Metastases - Reply

Debu Tripathy, Sara M. Tolaney, Mary Tagliaferri

Breast Medical Oncology

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	1700-1701
Number of pages	2
Journal	JAMA Oncology
Volume	8
Issue number	11
DOIs	https://doi.org/10.1001/jamaoncol.2022.4346
State	Published - Nov 17 2022

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1001/jamaoncol.2022.4346

Cite this

@article{903379827733436cae09fd7b105e5ee8,

title = "Etirinotecan Pegol Treatment for Patients with Metastatic Breast Cancer and Brain Metastases - Reply",

author = "Debu Tripathy and Tolaney, {Sara M.} and Mary Tagliaferri",

year = "2022",

month = nov,

day = "17",

doi = "10.1001/jamaoncol.2022.4346",

language = "English (US)",

volume = "8",

pages = "1700--1701",

journal = "JAMA Oncology",

issn = "2374-2437",

publisher = "American Medical Association",

number = "11",

}

TY - JOUR

T1 - Etirinotecan Pegol Treatment for Patients with Metastatic Breast Cancer and Brain Metastases - Reply

AU - Tripathy, Debu

AU - Tolaney, Sara M.

AU - Tagliaferri, Mary

PY - 2022/11/17

Y1 - 2022/11/17

UR - http://www.scopus.com/inward/record.url?scp=85139179001&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85139179001&partnerID=8YFLogxK

U2 - 10.1001/jamaoncol.2022.4346

DO - 10.1001/jamaoncol.2022.4346

M3 - Letter

C2 - 36136348

AN - SCOPUS:85139179001

SN - 2374-2437

VL - 8

SP - 1700

EP - 1701

JO - JAMA Oncology

JF - JAMA Oncology

IS - 11

ER -

Etirinotecan Pegol Treatment for Patients with Metastatic Breast Cancer and Brain Metastases - Reply

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this